Bleakley Financial Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,001
| Closed | -$16.5K | – | 664 |
|
|
2024
Q4 | $16.5K | Sell |
10,001
-1,238
| -11% | -$2.04K | ﹤0.01% | 1039 |
|
|
2024
Q3 | $39.3K | Sell |
11,239
-180
| -2% | -$630 | ﹤0.01% | 1004 |
|
|
2024
Q2 | $37.5K | Buy |
11,419
+403
| +4% | +$1.32K | ﹤0.01% | 988 |
|
|
2024
Q1 | $80.9K | Buy |
11,016
+13
| +0.1% | +$95 | ﹤0.01% | 940 |
|
|
2023
Q4 | $41.2K | Sell |
11,003
-1,009
| -8% | -$3.77K | ﹤0.01% | 932 |
|
|
2023
Q3 | $25.5K | Buy |
+12,012
| New | +$25.5K | ﹤0.01% | 869 |
|